$0.00

Last traded 2023-06-07 — delisted

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · $90997 mcap · 842M float · 0.018% daily turnover

Revenue

$10M -35.7% ▼

Gross Profit

$3M -28.8% ▼

Operating Income

-$2M +27.6% ▲

Net Income

-$5M -42.2% ▼

EPS (Diluted)

$-0.01 -18.9% ▼

EBITDA

-$2M +27.6% ▲

View Full Income Statement

Line Item	FY2018	FY2019	FY2020
Revenue	$26M	$15M	$10M
YoY Growth	+0.0%	-41.1%	-35.7%
Cost of Revenue	$17M	$10M	$6M
Gross Profit	$9M	$5M	$3M
Gross Margin	35.0%	32.0%	35.4%
R&D Expenses	$0	$0	$0
SG&A Expenses	$9M	$8M	$3M
Operating Expenses	$9M	$8M	$5M
Operating Income	$253K	-$3M	-$2M
Operating Margin	1.0%	-20.1%	-22.7%
Interest Expense	$11K	$334K	$375K
Income Before Tax	$243K	-$3M	-$6M
Tax Expense	$0	$334K	-$320K
Net Income	$243K	-$4M	-$5M
Net Margin	0.9%	-24.6%	-54.4%
EPS (Diluted)	$0.00	$-0.01	$-0.01
EBITDA	$253K	-$3M	-$2M
Shares Outstanding	569M	701M	836M

Line Item	FY2019 Q1	FY2019 Q2	FY2019 Q3	FY2019 Q4	FY2020 Q1	FY2020 Q2	FY2020 Q3	FY2020 Q4
Revenue	$6M	$4M	$4M	$903K	$2M	$3M	$2M	$2M
Cost of Revenue	$4M	$3M	$2M	$2M	$953K	$2M	$2M	$2M
Gross Profit	$3M	$2M	$1M	-$783K	$1M	$938K	$804K	$607K
Gross Margin	41.2%	35.8%	39.9%	-86.8%	58.7%	31.5%	32.3%	27.5%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$2M	$1M	$2M	$2M	$1M	$859K	$1M	-$311K
Operating Expenses	$2M	$1M	$2M	$2M	$1M	$859K	$1M	$2M
Operating Income	$129K	$148K	-$420K	-$3M	$77K	$79K	-$377K	-$5M
Operating Margin	2.1%	3.4%	-11.6%	-320.9%	3.4%	2.7%	-15.1%	-212.5%
Interest Expense	$79K	$78K	$85K	$86K	$90K	$91K	$90K	$19K
Income Before Tax	$50K	$69K	-$505K	-$3M	-$12K	-$12K	-$467K	-$5M
Tax Expense	$0	$0	$0	$86K	$90K	$91K	$90K	$19K
Net Income	$50K	$69K	-$505K	-$3M	-$102K	-$104K	-$557K	-$5M
Net Margin	0.8%	1.6%	-13.9%	-339.9%	-4.4%	-3.5%	-22.4%	-214.1%
EPS (Diluted)	$0.00	$0.00	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00	$-0.01
EBITDA	$129K	$148K	-$420K	-$3M	$77K	$79K	-$377K	-$5M
Shares Outstanding	701M	701M	701M	701M	728M	728M	780M	836M

POTN OTC